BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Mar 15, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Picoplatin: Additional Phase II data

Additional data from a Phase II trial in 29 evaluable patients showed that picoplatin in combination with docetaxel and prednisone led to a median OS of 21.4 months compared to 18.9 months for patients who received docetaxel plus prednisone alone as reported in published literature....

Read the full 203 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >